ADAGE CAPITAL PARTNERS GP, L.L.C. - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 64 filers reported holding PROQR THRAPEUTICS N V in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$4,713,107
-19.8%
3,625,4670.0%0.01%
-15.4%
Q2 2023$5,873,257
-23.9%
3,625,4670.0%0.01%
-23.5%
Q1 2023$7,722,245
-42.4%
3,625,4670.0%0.02%
-46.9%
Q4 2022$13,414,228
+446.4%
3,625,467
+9.9%
0.03%
+433.3%
Q3 2022$2,455,000
-4.3%
3,300,0000.0%0.01%0.0%
Q2 2022$2,566,000
-14.1%
3,300,0000.0%0.01%0.0%
Q1 2022$2,987,000
-92.1%
3,300,000
-30.0%
0.01%
-91.2%
Q4 2021$37,768,000
-4.3%
4,715,1520.0%0.07%
-12.8%
Q3 2021$39,466,000
+24.7%
4,715,152
+0.4%
0.08%
+25.8%
Q2 2021$31,641,000
+2.0%
4,694,4650.0%0.06%
-1.6%
Q1 2021$31,030,000
+62.4%
4,694,465
+3.2%
0.06%
+50.0%
Q4 2020$19,110,000
-12.3%
4,550,0620.0%0.04%
-23.6%
Q3 2020$21,795,000
-21.2%
4,550,0620.0%0.06%
-22.5%
Q2 2020$27,664,000
+10.7%
4,550,0620.0%0.07%
-5.3%
Q1 2020$24,980,000
-44.9%
4,550,062
-0.5%
0.08%
-32.4%
Q4 2019$45,302,000
+110.5%
4,571,319
+22.4%
0.11%
+109.4%
Q3 2019$21,517,000
-36.7%
3,735,5070.0%0.05%
-37.6%
Q2 2019$33,993,000
-34.4%
3,735,5070.0%0.08%
-34.6%
Q1 2019$51,811,000
-12.1%
3,735,5070.0%0.13%
-20.2%
Q4 2018$58,946,000
-12.0%
3,735,507
+7.9%
0.16%
+9.4%
Q3 2018$66,989,000
+324.4%
3,461,941
+60.1%
0.15%
+313.9%
Q2 2018$15,786,000
+242.2%
2,162,527
+44.2%
0.04%
+227.3%
Q1 2018$4,613,000
+43.0%
1,500,000
+50.0%
0.01%
+57.1%
Q4 2017$3,225,0001,000,0000.01%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q2 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders